OMER - Omeros GAAP EPS of -$0.82 misses by $0.17
2023-11-09 16:27:39 ET
More on Omeros
- Omeros: Where Medical Hopes Tangle With Fiscal Ropes
- Omeros: Betting Big On Narsoplimab, We Are Still A Buyer
- Omeros Q3 2023 Earnings Preview
- Omeros stock plunges 48% on failed Phase 3 study for narsoplimab
- Seeking Alpha’s Quant Rating on Omeros
For further details see:
Omeros GAAP EPS of -$0.82 misses by $0.17